Latest

Market news by symbol, source, and language

20 stories
tradingview

SPAR Group Special Meeting Adjourned for Lack of Quorum; Reconvenes July 10

SPAR Group announced its July 6 special meeting was adjourned for lack of a quorum and will reconvene virtually on July 10, 2026.Key Highlights:Original SEC Filing: SPAR Group, Inc. [ SGRP ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying importan…

TradingView en_IN
StocksUS
tradingview

ClearSign to Relaunch $6.875M At-The-Market Equity Offering

ClearSign filed a prospectus supplement to recommence an at-the-market offering to sell up to $6,875,000 of common stock.Key Highlights:Original SEC Filing: ClearSign Technologies Corp [ CLIR ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying impor…

TradingView en_IN
StocksUS
tradingview

CytoSorbents Disclosed Failure to Satisfy a Continued Listing Rule or Standard

On June 29, 2026, the company received notice from Nasdaq that it is not in compliance with Listing Rule 5550(b)(2) because its market value of listed securities fell below the $35 million minimum. Nasdaq granted 180 days, until December 28, 2026, to regain compliance by meeting or exceeding $35 mi…

TradingView en_IN
StocksUS
tradingview

Laurie Keating elected to Kalaris board as Morana Jovan-Embiricos resigns

Kalaris appointed Laurie Keating to its board and Audit Committee, effective August 1, 2026, following the immediate resignation of Morana Jovan-Embiricos from the board and Audit Committee on July 3, 2026.Original SEC Filing: Kalaris Therapeutics, Inc. [ KLRS ] - 8-K - Jul. 06, 2026This is an AI-p…

TradingView en_IN
StocksUS
tradingview

Monica Bertagnolli resigns from Natera board to join National Academy of Medicine

Natera director Monica Bertagnolli resigned from the board and all board committees effective July 1, 2026, to assume a new position with the National Academy of Medicine.Original SEC Filing: Natera, Inc. [ NTRA ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Cons…

TradingView en_IN
StocksUS
tradingview

Nomadar appoints Joaquin Martin to Board; Manuel Vizcaino resigns as co‑chairman

Nomadar appointed Joaquin Martin to its board effective July 3, 2026, and Manuel Vizcaino resigned as co‑chairman and director on the same date.Original SEC Filing: Nomadar Corp. [ NOMA ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important i…

TradingView en_IN
StocksUS
tradingview

Oragen appoints John Spencer as Chief Financial Officer

Oragen appointed John Spencer as Chief Financial Officer, effective July 1, 2026.Original SEC Filing: ORAGENICS INC [ OGEN ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely…

TradingView en_IN
StocksUS
tradingview

Steven Kemps to Retire as S&P Global Chief Legal Officer, Effective Dec 31, 2026

S&P Global announced that Steven Kemps will retire as Executive Vice President and Chief Legal Officer, effective December 31, 2026.Original SEC Filing: S&P Global Inc. [ SPGI ] - 8-K - Jul. 06, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information…

TradingView en_IN
StocksUS
trading-economics

US Stocks Rise as Chipmakers Rally

US stock indices closed higher on Monday on strong gains in semiconductor stocks.The S&P 500 added 0.7%, the Nasdaq 100 rose 1.3%, and the Dow closed at a record high of 53,056.Chipmakers rallied ahead of Samsung's sales update and SK Hynix's ADR issuance on Friday.Broadcom rose 3.7% after extendin…

Trading Economics en_IN
index

Vertex to buy Crinetics for $10 billion to expand rare-disease business

Vertex Pharmaceuticals NASDAQ:VRTX will buy Crinetics Pharmaceuticals NASDAQ:CRNX for a total equity value of about $10 billion, the companies said on Monday, adding treatments for rare hormonal diseases to its portfolio.Vertex's offer of $85 per Crinetics share represents a 102% premium to the sto…

Reuters en_IN
StocksUS
tradingview

PBF Energy 10% Owner Sold Shares Worth Over $9.3M

Control Empresarial De Capitales S.A. De C.V., a 10% owner, reported the direct sale of Class A Common Shares on 2026-07-01. The shares were sold at a weighted average price of $46.9433 per share with individual prices ranging from $46.50 to $47.41. The total sale amount reported was $9,388,660. Fo…

TradingView en_IN
StocksUS